Secondary Logo

Journal Logo

Most Popular Articles

ACE2 polymorphism and susceptibility for SARS-CoV-2 infection and severity of COVID-19

Möhlendick, Birte; Schönfelder, Kristina; Breuckmann, Katharina; More

Pharmacogenetics and Genomics. 31(8):165-171, October 2021.

Generating evidence for precision medicine: considerations made by the Ubiquitous Pharmacogenomics Consortium when designing and operationalizing the PREPARE study

van der Wouden, Cathelijne H.; Böhringer, Stefan; Cecchin, Erika; More

Pharmacogenetics and Genomics. 30(6):131-144, August 2020.

CYP2D6 function moderates the pharmacokinetics and pharmacodynamics of 3,4-methylene-dioxymethamphetamine in a controlled study in healthy individuals

Schmid, Yasmin; Vizeli, Patrick; Hysek, Cédric M.; More

Pharmacogenetics and Genomics. 26(8):397-401, August 2016.

Pharmacogenetic assessment of tafenoquine efficacy in patients with Plasmodium vivax malaria

St Jean, Pamela L.; Koh, Gavin C.K.W.; Breton, John J.; More

Pharmacogenetics and Genomics. 30(7):161-165, September 2020.

Characterization of ADME gene variation in 21 populations by exome sequencing

Hovelson, Daniel H.; Xue, Zhengyu; Zawistowski, Matthew; More

Pharmacogenetics and Genomics. 27(3):89-100, March 2017.

Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions

Hung, Shuen-Iu; Chung, Wen-Hung; Jee, Shiou-Hwa; More

Pharmacogenetics and Genomics. 16(4):297-306, April 2006.

Utility of integrated pharmacogenomic testing to support the treatment of major depressive disorder in a psychiatric outpatient setting

Hall-Flavin, Daniel K.; Winner, Joel G.; Allen, Josiah D.; More

Pharmacogenetics and Genomics. 23(10):535-548, October 2013.

CYP2C9 variants as a risk modifier of NSAID-related gastrointestinal bleeding: a case–control study

Figueiras, Adolfo; Estany-Gestal, Ana; Aguirre, Carmelo; More

Pharmacogenetics and Genomics. 26(2):66-73, February 2016.

A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of colorectal cancer

Landi, Stefano; Gemignani, Federica; Moreno, Victor; More

Pharmacogenetics and Genomics. 15(8):535-546, August 2005.

Multiphenotype association study of patients randomized to initiate antiretroviral regimens in AIDS Clinical Trials Group protocol A5202

Verma, Anurag; Bradford, Yuki; Verma, Shefali S.; More

Pharmacogenetics and Genomics. 27(3):101-111, March 2017.

Two polymorphic gene loci associated with treprostinil dose in pulmonary arterial hypertension

Thomeas-McEwing, Vasiliki; Psotka, Mitchell A.; Gamazon, Eric R.; More

Pharmacogenetics and Genomics. 32(4):144-151, June 2022.

A European study of HLA-B in Stevens–Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs

Lonjou, Christine; Borot, Nicolas; Sekula, Peggy; More

Pharmacogenetics and Genomics. 18(2):99-107, February 2008.

Strong association between HLA-B*5801 and allopurinol-induced Stevens–Johnson syndrome and toxic epidermal necrolysis in a Thai population

Tassaneeyakul, Wichittra; Jantararoungtong, Thawinee; Chen, Pei; More

Pharmacogenetics and Genomics. 19(9):704-709, September 2009.

The functional G143E variant of carboxylesterase 1 is associated with increased clopidogrel active metabolite levels and greater clopidogrel response

Lewis, Joshua P.; Horenstein, Richard B.; Ryan, Kathleen; More

Pharmacogenetics and Genomics. 23(1):1-8, January 2013.

4β-Hydroxycholesterol is a new endogenous CYP3A marker: relationship to CYP3A5 genotype, quinine 3-hydroxylation and sex in Koreans, Swedes and Tanzanians

Diczfalusy, Ulf; Miura, Jun; Roh, Hyung-Keun; More

Pharmacogenetics and Genomics. 18(3):201-208, March 2008.

Confirmation of −174G/C interleukin-6 gene promoter polymorphism as a genetic marker predicting antitumor necrosis factor treatment outcome

Dávila-Fajardo, Cristina L.; Márquez, Ana; Pascual-Salcedo, Dora; More

Pharmacogenetics and Genomics. 24(1):1-5, January 2014.

Dapsone-induced severe cutaneous adverse drug reactions are strongly linked with HLA-B*13: 01 allele in the Thai population

Tempark, Therdpong; Satapornpong, Patompong; Rerknimitr, Pawinee; More

Pharmacogenetics and Genomics. 27(12):429-437, December 2017.

Genetic diversity of variants involved in drug response and metabolism in Sri Lankan populations: implications for clinical implementation of pharmacogenomics

Chan, Sze Ling; Samaranayake, Nilakshi; Ross, Colin J.D.; More

Pharmacogenetics and Genomics. 26(1):28-39, January 2016.

Pharmacogenetic characterization of naturally occurring germline NT5C1A variants to chemotherapeutic nucleoside analogs

Saliba, Jason; Zabriskie, Ryan; Ghosh, Rajarshi; More

Pharmacogenetics and Genomics. 26(6):271-279, June 2016.

Effect of CYP2C19 genetic variants on bleeding and major adverse cardiovascular events in a cohort of Arab patients undergoing percutaneous coronary intervention and stent implantation

Ali, Zainab Omer; Bader, Loulia; Mohammed, Shaaban; More

Pharmacogenetics and Genomics. : April 07, 2022

Targeted sequencing identifies a missense variant in the BEST3 gene associated with antihypertensive response to hydrochlorothiazide

Singh, Sonal; Wang, Zhiying; Shahin, Mohamed H.; More

Pharmacogenetics and Genomics. 28(11):251-255, November 2018.

The use of a DNA biobank linked to electronic medical records to characterize pharmacogenomic predictors of tacrolimus dose requirement in kidney transplant recipients

Birdwell, Kelly A.; Grady, Ben; Choi, Leena; More

Pharmacogenetics and Genomics. 22(1):32-42, January 2012.

Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity

Hertz, Daniel L.; Douglas, Julie A.; Kidwell, Kelley M.; More

Pharmacogenetics and Genomics. 31(5):116-123, July 2021.

Angiotensin-converting enzyme activity in Cavalier King Charles Spaniels with an ACE gene polymorphism and myxomatous mitral valve disease

Meurs, Kathryn M.; Olsen, Lisbeth H.; Reimann, Maria J.; More

Pharmacogenetics and Genomics. 28(2):37-40, February 2018.

Risk factors of allopurinol-induced severe cutaneous adverse reactions in a Thai population

Saksit, Niwat; Tassaneeyakul, Wichittra; Nakkam, Nontaya; More

Pharmacogenetics and Genomics. 27(7):255-263, July 2017.

Candidate HLA genes for prediction of co-trimoxazole-induced severe cutaneous reactions

Kongpan, Thachanan; Mahasirimongkol, Surakameth; Konyoung, Parinya; More

Pharmacogenetics and Genomics. 25(8):402-411, August 2015.

Anesthesia providers as stakeholders to adoption of pharmacogenomic information in perioperative care

Truong, Tien M.; Apfelbaum, Jeffrey L.; Schierer, Emily; More

Pharmacogenetics and Genomics. 32(3):79-86, April 2022.